GENIE : Genomic engineering in epigenetics

The “Genome ENgeneering In Epigenetics” (GENIE) platform focuses on the various applications of CRISPR/Cas technologies in the field of epigenetics.


CRISPR/Cas-based applications for epigenetic studies


GENIE assists researchers in the planning of experiments and the assembly of reagents for the generation of custom experimental systems. We provide expertise and tools for various genome and epigenome engineering applications.

Our goal is to facilitate the choice of genome editing, epigenome and other tools based on CRISPR/Cas technologies. GENIE is open to all members of the UMR7216 Epigenetics and Cell Fate unit and to a certain extent to members of the transverse programs of the Labex “Who am I?”. The acceptance of external projects is possible after discussion with the steering committee and depends on the resources available.


Our expertise lies in the following areas:

  • Genome editing: knock-out, knock-in, and point mutation introduction
  • Modulation of gene expression and modification of the epigenome
  • Use of CRISPR/Cas technologies for imaging or for identification of protein composition of the locus of interest using proximity tagging techniques
  • CRISPR/Cas targeting of RNA for degradation, imaging, or editing


  • Access to the bank of molecular tools for genome engineering, epigenomes and RNA modifications.
  • Protocols, advice, and technical support for genome and epigenome engineering and other applications based on CRISPR/Cas technologies.
  • Implementations of novel CRISPR/Cas-based approaches adapted to the needs of the unit.
  • Training for new users in CRISPR-based technologies in a form of a course on genome and epigenome editing.

In collaboration with other platforms of the unit, GENIE assists in determining the optimal guide sequences and/or recombination template and in designing the optimal engineering strategy for each project, with an emphasis on easy downstream screening. We also help to choose the best way to deliver components for (epi)gene editing into cells. Besides the classical transfection reagents or nucleofection available in the EDC teams, full support can be provided for lentiviral delivery systems in collaboration with  Vectorology platform.



Ekaterina Boyarchuk





Bank of molecular tools for genome and epigenome engineering

To get access to GENIE’s bank of vectors, contact us




Lamarck B building, room 411

35 rue Hélène Brion, 75013 Paris


Steering committee

Joined steering committee for GENIE and Vectorology platforms:




Read more

Laetitia Aubry seminar – April 24, 2024

Laetitia Aubry seminar – April 24, 2024

Wednesday, April 24, 2024, at 11:00 am. Laetitia Aubry Université d’Evry / I-StemInvited by Valérie Drouet “Harnessing pluripotent stem cells derivatives from patients with Wolfram syndrome to reveal pathological mechanisms and identify potential therapeutic chemical...

Moussa Benhamed seminar – April 17, 2024

Moussa Benhamed seminar – April 17, 2024

Wednesday, April 17, 2024, at 11:00 am. Moussa Benhamed Institute of Plant Sciences, Paris SaclayInvited by Valérie Mezger “Exploring the chromatin-based regulation of enhancer-promoter contact and its impact on gene expression” The seminar will take place in the...

Professional afterwork – April 22, 2024

Professional afterwork – April 22, 2024

Do you know what else exists outside academia?Come to talk about it with our two guests on Monday, April 22, 2024, at 6.15 pm. Where? Epigenetics and Cell Fate Center (EDC)Université Paris Cité - 35 Rue Helene Brion 75013 Paris – Lamarck B building - Hall (Upper...